Value of Glycogen Synthase 2 in intrahepatic cholangiocarcinoma prognosis assessment and its influence on the activity of cancer cells
Intrahepatic cholangiocarcinoma is the second most common primary liver tumor with increasing incidence worldwide. Metabolic reprogramming caused by metabolic related gene disorders is a prominent hallmark of tumors, among which Glycogen Synthase 2 (GYS2) is the key gene responsible for regulating c...
Enregistré dans:
Auteurs principaux: | Sigen A, Huijun Wu, Xiaodong Wang, Xidong Wang, Jiarui Yang, Long Xia, Yijun Xia |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Taylor & Francis Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/45a90d9ad03f4d1cacdeca0c0a3144e7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
par: Serifis N, et autres
Publié: (2021) -
TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma
par: Chen,Yijie, et autres
Publié: (2015) -
An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection
par: He C, et autres
Publié: (2021) -
Immobilization of Glycogen Synthase Kinase-3β Inhibitor on 316L Stainless Steel via Polydopamine to Accelerate Endothelialization
par: Ming Zhang, et autres
Publié: (2021) -
A Novel Clinical-Radiomics Model Based on Sarcopenia and Radiomics for Predicting the Prognosis of Intrahepatic Cholangiocarcinoma After Radical Hepatectomy
par: Liming Deng, et autres
Publié: (2021)